Search results for: OHE Consulting
Filter search results
ISPOR Europe Round-up: “Gene Therapies: Where High Promise Meets High Uncertainty, How Should HTA Methodologies Appropriately Value and Enable Access?”
8 December 2022
…the session and speakers: Dr Amanda Cole, Senior Principal Economist at OHE Josie Godfrey, Director at JG Zebra Consulting Dr Ruth Kim, Value & Evidence Team Leader, Rare Disease and…
Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism
30 March 2023
…years, the aim should be a full population-level economic evaluation, linked to QALY, and incorporating an antibiotic’s STEDI value. This consulting report, ‘Incentivising New Antibiotics: Designing a Value-Based Delinked Pull…
Delivering the Triple Win: A Value-Based Approach to Pricing
20 April 2023
…seven of nine countries. This consulting report, ‘Delivering the Triple Win: A Value-Based Approach to Pricing’ was commissioned and funded by the European Federation of Pharmaceutical Industries and Associations (EFPIA)….
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe
2 June 2023
…improved uptake of NGS for lung cancer in Europe This consulting report, ‘The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe’, was commissioned and funded by…
Raoh-Fang Pwu
15 May 2023
…Pwu, along with several colleagues from her college, co-founded a consulting company specializing in clinical/epidemiological research design and data analysis. However, her career took a turn in 2007 when the…
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
11 July 2023
…by dementia but will also facilitate long-term economic growth and stability in the UK. This consulting report, ‘Dementia in the UK: Estimating the Potential Future Impact and Return on Research…
The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society
18 July 2023
…input from our patient and clinician focus group. Key Recommendations: This consulting report. ‘The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society’, was commissioned and funded by M&F…
Stuart Carroll
30 August 2023
…affairs and government policy. He has his own expert consultancy business, Stuart Carroll Healthcare Consulting Ltd, and a joint enterprise with Professor Sir Jonathan Van Tam, CVT Market Access Solutions Ltd. …
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
…post-Brexit activities could weaken the influence of NICE, particularly in Europe. This consulting report, ‘NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?’, was commissioned and funded by Sanofi…